Cite

HARVARD Citation

    Araki, T. et al. (2016). Amrubicin in patients with platinum-refractory metastatic neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the gastrointestinal tract. Anti-cancer drugs. 27 (8), p. . [Online]. 
  
Back to record